General Practice Doctors in Juana Diaz, PR Accepting Medicare

47 General Practice doctors found. Showing 41 - 47

Dr. Gustavo Adolfo Munoz, General Practice Medicare: Accepting Medicare Assignments Practice Location: 6 Calle La Cruz, Juana Diaz, PR 00795 Phone: 787-837-2265

Dr. Nelmary Hernandez Rivera, MD General Practice Medicare: Medicare Enrolled Practice Location: 4b Calle Hostos, Juana Diaz, PR 00795 Phone: 787-973-0110

Isis Torres Rosario, MD General Practice Medicare: Medicare Enrolled Practice Location: 162 Calle El Flamboyan, Urb Valle Hucares, Juana Diaz, PR 00795 Phone: 787-248-6095

Dr. Roel Elfrieth Gardeslen, MEDICINE General Practice Medicare: Not Enrolled in Medicare Practice Location: #5 Urb.las Flores J7, Juana Diaz, PR 00795 Phone: 787-901-0815

Dr. Yiselle Lopez Ortiz, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 40 Calle Costa Real, Urb Camino Real, Juana Diaz, PR 00795 Phone: 787-837-2513

Dr. Robert Andrew Engel Rodriguez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Urb Palacios Del Prado, 54 Ave Atlantico, Juana Diaz, PR 00795 Phone: 787-370-6912

Dr. Raul Chardon Burgos, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 149 Bo. Las Lomas, Juana Diaz, PR 00795 Phone: 787-837-3400    Fax: 787-837-3400

News Archive

Largest remote health monitoring project in the world launched in China

Canada-based IDEAL LIFE and China's Shandong NovaTech Biological Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer and medical products distribution network in China, announced the launch of the largest remote health monitoring project in the world, bringing wireless, remote health monitoring to the People's Republic of China.

Experts to discuss China's aging problem at Retirement Living World China 2011

From the 24th to the 27th of May 2011, retirement industry leaders from China and the rest of the world will meet at Retirement Living World China 2011. The event will be hosted by China Association of Social Workers and in partnership with IMAPAC.

Trial reinforces safety and efficacy of Boston Scientific's two drug-eluting stent platforms

Boston Scientific Corporation has welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of two-year data from the SPIRIT II and III Trials.

Metabolic characteristics of CRPC may open new avenues for treatment

Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the tumor becoming castration resistant- a lethal condition.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)